Healthcare and Pharmaceuticals
GLOBAL MEDICAL MARIJUANA MARKET was valued at USD 9.01 Billion in the year 2017. Global Medical marijuana market is further estimated to grow at a CAGR of 16.90% from 2018 to reach USD 23.3 Billion by the year 2023.
North America region holds the highest market share in 2017 and Europe market is considered as the fastest growing market in the forecasted period due to growing demand in the healthcare industry and technological advancements. At a country level, U.S & Canada is projected to grow strongly in the coming years.
Canopy Growth Corporation (Canada), Medical Marijuana, Inc. (U.S), GW Pharmaceuticals, plc (U.K), United Cannabis (U.S), Cannabis Sativa, Inc. (U.S), GreenGro Technologies (U.S), Aurora Cannabis (Canada), Cara Therapeutics (U.S) and GBSciences, Inc. (U.S) are the key players in the Global Medical marijuana market. Better global reach at an operational level is the main reason the key players are holding substantial market share. Rising research and development expenses to satisfy the changing demands of end users, new product launches and organic growth strategies were few techniques adopted by various manufacturers in last 5 years.
The expansion of marijuana legalization in the U.S.
The stigma of marijuana in society
Lack of federal support
Cannabis as healthcare treatment
The segmentation are done on the basis of Type of marijuana, by chemical component, by application, by end-use and by region. On the basis of Product Type, the Sativa segment is expected to hold the highest market share during the forecast period due to growing awareness and high demand. The segmentation done on the basis of Chemical Component the Tetrahydrocannabinol (THC) segment is expected to hold the highest market share.
Medical Marijuana Industry on the basis of application in this report include Cancer, Arthritis, and Alzheimer’s, Pain Management, Multiple Sclerosis and Others. Pain Management segment hold the largest share and it is also the fastest growing with the CAGR of XX% in the forecasted period.
The segmentation done on the basis of end use includes hospital, pharmaceutical industry and research and development centers of which the pharmaceutical industry segment is expected to hold the highest market share during the forecast period.
Key Benefits for Stakeholders
Medical marijuana Manufacturers, Distributors and Retailers
Raw material suppliers
Research and Consulting Organization
Medical and, R&D and healthcare institutions
By Product Type
By Chemical Component
Hybrid (Combination of THC & CBD)
Research and Development Centers
Key Market Players
Canopy Growth Corporation
GW Pharmaceuticals, PLC
Medical Marijuana, Inc.
United Cannabis Corporation
Cannabis Sativa, Inc.
United Cannabis Corporation
(A brief overview of 10 companies is also provided)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet with your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
188.8.131.52. Key Data from Secondary Research
2.1.2. Primary Research
184.108.40.206. Key Data from Primary Research
220.127.116.11. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Medical Marijuana Market, By Product Type
7. Medical Marijuana Market, By Chemical Component
7.1. Tetrahydrocannabinol (THC)
7.2. Cannabidiol (CBD)
7.3. Hybrid (Combination of THC & CBD)
8. Medical Marijuana Market, By Application
8.4. Pain Management
8.5. Multiple Sclerosis
9. Medical Marijuana Market, End-Use
9.2. Pharmaceutical Industry
9.3. Research and Development Centers
10. Geographical Analysis
10.2. North America
10.4. Asia Pacific
10.4.1. South Korea
10.5.1. Latin America
10.5.2. Middle East and Africa
11. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
11.1. Canopy Growth Corporation
11.2. GW Pharmaceuticals, PLC
11.3. Medical Marijuana, Inc.
11.4. United Cannabis Corporation
11.5. Cannabis Sativa, Inc.
11.6. GreenGro Technologies
11.7. Aurora Cannabis
11.8. United Cannabis Corporation
11.9. Cara Therapeutics.
11.10. GBSciences, Inc.
(Another brief information of 10 companies will be provided in report.)
12. Competitive Analysis
12.2. Market Positioning of Key Players
12.3 Competitive Strategies Adopted by Leading Players
12.3.1. Investments & Expansions
12.3.2. New Product Launches
12.3.3. Mergers & Acquisitions
12.3.4. Agreements, Joint Ventures, and Partnerships
13.2. Available Customizations
13.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
No Content Available.